Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas.
Cancer Control
; 28: 10732748211040013, 2021.
Article
in En
| MEDLINE
| ID: mdl-34620004
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Mitogen-Activated Protein Kinases
/
Proto-Oncogene Proteins B-raf
/
Glioma
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cancer Control
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: